Author details

Full Name

Keren Rabinowitz

Affiliation

ORCID

Career Start Year

2011

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37515078	Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases.		2023
37941598	A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn's Disease Treated by a Multidisciplinary Team: 1-Year Outcomes.		2023
36969163	Human intestinal epithelial cells can internalize luminal fungi LC3-associated phagocytosis.		2023
34717923	Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFÎ±.	Gastroenterology	2022
36366342	SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy.	Vaccines	2022
36226673	Increasing adherence to the Mediterranean diet and lifestyle is associated with reduced fecal calprotectin and intra-individual changes in microbial composition of healthy subjects.	Gut Microbes	2022
35893835	Anti-TNFÎ± Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases.	Vaccines	2022
35560165	Escherichia coli Strains from Patients with Inflammatory Bowel Diseases have Disease-specific Genomic Adaptations.		2022
36498474	Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts.		2022
34928348	Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.	Inflamm Bowel Dis	2022
35175302	Corrigendum to: Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.	Inflamm Bowel Dis	2022
32629126	Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable.	Clinical Gastroenterology and Hepatology	2021
34111242	Alteration in Urease-producing Bacteria in the Gut Microbiomes of Patients with Inflammatory Bowel Diseases.		2021
33616974	Commensal fungi and their cell-wall Î²-glucans direct differential responses in human intestinal epithelial cells.	European Journal of Immunology	2021
33653942	Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease.	mSystems	2021
31605691	Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.	Gastroenterology	2020
30666957	Gut microbiota density influences host physiology and is shaped by host and microbial factors.	Elife	2019
30265311	Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.	Inflammatory Bowel Diseases	2019
29618496	Cell-centred meta-analysis reveals baseline predictors of anti-TNFÎ± non-response in biopsy and blood of patients with IBD.	Gut	2019
29688474	Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.	Inflammatory Bowel Diseases	2018
23232296	Transforming growth factor Î² signaling controls activities of human intestinal CD8(+)T suppressor cells.	Gastroenterology	2013
22466933	Working out mechanisms of controlled/physiologic inflammation in the GI tract.	Immunologic Research	2012
21056041	Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4+ T cells, in mice and humans.	Gastroenterology	2011